TrialWire Technology Platform Announces Success-based Patient Recruitment Plan TrialWire Jul 18, 2022 15:00 HKT/SGT Read More
Malaysian Genomics Appoints New Chairman Malaysian Genomics Resource Centre Bhd Jul 15, 2022 14:10 HKT/SGT Read More
노보텍 고객사 SK바이오사이언스, 스카이코비원(SKYCovione(TM)) 코로나19 백신 국내 승인 Novotech Health Holdings Pte Ltd Jul 14, 2022 20:00 HKT/SGT Read More
贝康医疗与海尔生物强强联合,构建辅助生殖低温保存解决方案 Suzhou Basecare Medical Corporation Limited Jul 14, 2022 13:25 HKT/SGT Read More
貝康醫療與海爾生物強強聯合,構建輔助生殖低溫保存解決方案 Suzhou Basecare Medical Corporation Limited Jul 14, 2022 13:24 HKT/SGT Read More
Basecare Medical and Haier Biomedical Join Forces to Build Cryopreservation Solutions for Assisted Reproduction Suzhou Basecare Medical Corporation Limited Jul 14, 2022 13:23 HKT/SGT Read More
Novotech 客户 SK bioscience 在韩国获得 SKYCovione(TM) COVID-19 疫苗批准 Novotech Health Holdings Pte Ltd Jul 14, 2022 08:00 HKT/SGT Read More
Novotech 客戶 SK bioscience 在韓國獲得 SKYCovione(TM) COVID-19 疫苗批准 Novotech Health Holdings Pte Ltd Jul 14, 2022 08:00 HKT/SGT Read More
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG and Apollo REVISE, New Endoscopic Systems for Patients with Obesity Apollo Endosurgery, Inc Jul 13, 2022 19:30 HKT/SGT Read More
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia Malaysian Genomics Resource Centre Bhd Jul 13, 2022 15:00 HKT/SGT Read More
Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea Novotech Health Holdings Pte Ltd Jul 13, 2022 14:30 HKT/SGT Read More
SinoMab Received the Highest Subsidy from HKSTP SinoMab BioScience Limited Jul 08, 2022 19:03 HKT/SGT Read More
Malaysian Genomics Proposes Private Placement Malaysian Genomics Resource Centre Bhd Jul 08, 2022 18:00 HKT/SGT Read More
Co-led by Legend Capital, Huili Biotechnology Completes Series A Financing Round with Hundreds of Million RMB Legend Capital Jul 07, 2022 19:13 HKT/SGT Read More
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles Malaysian Genomics Resource Centre Bhd Jul 06, 2022 16:00 HKT/SGT Read More
エーザイ、抗アミロイドβ(Aβ)プロトフィブリル抗体「レカネマブ」について、迅速承認制度に基づく、早期アルツハイマー病に対する生物製剤ライセンス申請が米国FDAに受理され、優先審査に指定 Eisai Jul 06, 2022 10:00 JST Read More